Global Blood Transfusion Diagnostics Market Anticipated to Expand Consistently During 2017 - 2025

A latest research report titled as “Blood Transfusion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic and the comprehensiveness of contents.

Request For Free Sample Report @ https://www.mrrse.com/sample/3375

The demand in the global market for blood transfusion diagnostics is projected to expand at a substantial CAGR of 6.8% during the forecast period of 2017 to 2025. This prosperity of the blood transfusion diagnostics market can be attributed to a number of factors, such as recent technological advancements and automation in blood processing equipment, growing number of blood transfusion procedures, consistent awareness programs by government and healthcare agencies, and the development of WHO recommended national blood policy. On the other hand, low blood donation rate and stringent regulations pertaining to safe blood transfusion are two obstructions faced by this market. The global blood transfusion diagnostics market is estimated to increment from an evaluated worth of US$3.3 bn in 2016 and reach a valuation of US$6.0 bn by the end of the forecast period, which is 2025.

Kits and Reagents In-demand Product Segment

Based on product-type, the global blood transfusion diagnostics market has been segmented into kits & reagents and instruments. The kits & reagents segment accounted for the most prominent share of the global blood transfusion diagnostics market in 2016, which was a reflection of their proven benefits in early recognition of the disease and blood grouping. However, the instruments segment is projected to expand at a significantly slower growth rate during the forecast period with the increasing modernization of the automated tools.

Application-wise, the global market for blood transfusion diagnostics has been bifurcated into blood grouping and disease screening. The disease screening category has been further divided into molecular disease screening and serological disease screening. In 2016, the disease screening segment dominated the global blood transfusion diagnostics market, highlighting the need for procedures that can ensure that all donated blood is safe and recipients get the safest products.  However, blood grouping segment is expected to grow at a slower rate during the forecast period owing. This is owing to the introduction of technologically advanced products that can perform blood grouping and disease screening at the same time in one step. The molecular disease screening sub-segment held a major market share in 2016, whereas serological disease screening sub-segment is anticipated to expand at a high CAGR during forecast period. In terms of end-users, the global blood transfusion diagnostics market gains maximum share of demand from hospitals, significantly more than diagnostic laboratories and blood banks.

Browse Full Report with TOC @ https://www.mrrse.com/blood-transfusion-market

Asia Pacific Projected for Most Impressive Growth Rate

North America held majority share of 43.1% of the global blood transfusion diagnostics market in 2016, followed by Europe at roundabout quarter of the overall demand. North America is expected to continue its dominance in the market during the forecast period, gaining traction from factors such as rapid rise in the number of cardiac surgical patients and introduction of innovative semi and full automated blood transfusion platforms. Cardiac surgical patients are the major consumers of blood banks. An estimated 20% of all the blood transfusion in North America is associated with cardiac surgical procedures. On the other hand, emerging countries in Asia Pacific, such as China, India, and South Korea, are expected to witness strong growth from 2017 to 2025. This is attributed to high investments made by the major players in the region and growing awareness about transfer of disease during blood transfusion in these countries.

Some of the prominent companies participating in the global blood transfusion diagnostics market are Ortho-Clinical Diagnostics, Inc., Immucor Inc., Bio-Rad Laboratories, Inc. Abbott Laboratories, BAG Health Care GmbH, Becton, Dickinson and Company, Quotient, Ltd., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Hologic, Inc., and Grifols, S.A.

Enquire about this Report @ https://www.mrrse.com/enquiry/3375

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website : www.mrrse.com
Read More Industry News At: www.industrynewsanalysis.com/

This release was published on openPR.